Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Daxor Corporation stock | $12.5

Own Daxor Corporation stock in just a few minutes.

Fact checked

Daxor Corporation is an asset management business based in the US. Daxor Corporation shares (DXR) are listed on the NYSE MKT and all prices are listed in US Dollars.

How to buy shares in Daxor Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Daxor Corporation. Find the stock by name or ticker symbol: DXR. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Daxor Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$12.5, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Daxor Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Daxor Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Daxor Corporation share price

Use our graph to track the performance of DXR stocks over time.

Daxor Corporation shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$12.5
52-week rangeUSD$8.47 - USD$20.44
50-day moving average USD$13.1745
200-day moving average USD$15.2503
Wall St. target priceUSD$21
PE ratio 118.75
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.053

Buy Daxor Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Daxor Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Daxor Corporation price performance over time

Historical closes compared with the close of $12.5 from 2020-12-31

1 week (2021-01-08) 2.21%
1 month (2020-12-16) -5.30%
3 months (2020-10-16) -15.77%
6 months (2020-07-16) -30.52%
1 year (2020-01-16) 31.95%
2 years (2019-01-16) -13.79%
3 years (2018-01-16) 190.70%
5 years (2016-01-15) 64.47%

Is Daxor Corporation under- or over-valued?

Valuing Daxor Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Daxor Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Daxor Corporation's P/E ratio

Daxor Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 119x. In other words, Daxor Corporation shares trade at around 119x recent earnings.

Daxor Corporation financials

Revenue TTM USD$306,165
Gross profit TTM USD$380,141
Return on assets TTM -0.43%
Return on equity TTM -36.19%
Profit margin 0%
Book value $2.869
Market capitalisation USD$51.7 million

TTM: trailing 12 months

Shorting Daxor Corporation shares

There are currently 13,131 Daxor Corporation shares held short by investors – that's known as Daxor Corporation's "short interest". This figure is 0.9% down from 13,254 last month.

There are a few different ways that this level of interest in shorting Daxor Corporation shares can be evaluated.

Daxor Corporation's "short interest ratio" (SIR)

Daxor Corporation's "short interest ratio" (SIR) is the quantity of Daxor Corporation shares currently shorted divided by the average quantity of Daxor Corporation shares traded daily (recently around 1859.9150141643). Daxor Corporation's SIR currently stands at 7.06. In other words for every 100,000 Daxor Corporation shares traded daily on the market, roughly 7060 shares are currently held short.

However Daxor Corporation's short interest can also be evaluated against the total number of Daxor Corporation shares, or, against the total number of tradable Daxor Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Daxor Corporation's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Daxor Corporation shares in existence, roughly 0 shares are currently held short) or 0.0034% of the tradable shares (for every 100,000 tradable Daxor Corporation shares, roughly 3 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Daxor Corporation.

Find out more about how you can short Daxor Corporation stock.

Daxor Corporation share dividends

We're not expecting Daxor Corporation to pay a dividend over the next 12 months.

Daxor Corporation share price volatility

Over the last 12 months, Daxor Corporation's shares have ranged in value from as little as $8.47 up to $20.44. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Daxor Corporation's is -0.8966. This would suggest that Daxor Corporation's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Daxor Corporation has bucked the trend.

Daxor Corporation overview

Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. Daxor Corporation has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences for researching the effectiveness of BVA-100 diagnostic test on quantifying circulatory blood volume in the context of traumatic injury. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site